|
1.
|
|
9 p, 627.4 KB |
Effects of alirocumab on types of myocardial infarction : Insights from the ODYSSEY OUTCOMES trial
/
White, Harvey D. (Auckland City Hospital) ;
Gabriel Steg, P. (Royal Brompton Hospital (Londres)) ;
Szarek, Michael (SUNY Downstate Medical Center School of Public Health) ;
Bhatt, Deepak L (Harvard Medical School) ;
Bittner, Vera A. (University of Alabama at Birmingham) ;
Diaz, Rafael (Instituto Cardiovascular de Rosario) ;
Edelberg, Jay M. (Sanofi) ;
Erglis, Andrejs (University of Latvia) ;
Goodman, Shaun G. (University of Toronto) ;
Hanotin, Corinne (Sanofi) ;
Harrington, Robert A. (Department of Medicine) ;
Wouter Jukema, J. (Leiden University Medical Center) ;
Lopes, Renato D. (Duke Clinical Research Institute) ;
Mahaffey, Kenneth W. (Stanford University School of Medicine) ;
Moryusef, Angele (Sanofi) ;
Pordy, Robert (Regeneron Pharmaceuticals) ;
Roe, Matthew T. (Duke Clinical Research Institute) ;
Sritara, Piyamitr (Mahidol University) ;
Tricoci, Pierluigi (CSL Behring) ;
Zeiher, Andreas Michael (Goethe University) ;
Schwartz, Gregory G. (University of Colorado School of Medicine) ;
Cequier Fillat, Angel R. (hospital Universitari de Bellvitge) ;
Garcia-Dorado, David (Hospital Universitari Vall d'Hebron) ;
Matas Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ;
Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ;
Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Coca Payeras, Antonio (Hospital Clínic i Provincial de Barcelona) ;
Universitat Autònoma de Barcelona
The third Universal Definition of Myocardial Infarction (MI) Task Force classified MIs into five types: Type 1, spontaneous; Type 2, related to oxygen supply/demand imbalance; Type 3, fatal without ascertainment of cardiac biomarkers; Type 4, related to percutaneous coronary intervention; and Type 5, related to coronary artery bypass surgery. [...]
2019 -  10.1093/eurheartj/ehz299
European heart journal, Vol. 40 Núm. 33 (january 2019) , p. 2801-2809
|
|
|
2.
|
|
10 p, 1.2 MB |
Association of candidate gene polymorphisms with chronic kidney disease : Results of a case-control analysis in the NEFRONA cohort
/
Valls, Joan (Instituto de Salud Carlos III) ;
Cambray, Serafí (Instituto de Salud Carlos III) ;
Pérez-Guallar, Carles (Instituto de Salud Carlos III) ;
Bozic, Milica (Instituto de Salud Carlos III) ;
Bermúdez-López, Marcelino (Instituto de Salud Carlos III) ;
Fernández, Elvira (Instituto de Salud Carlos III) ;
Betriu, Àngels (Instituto de Salud Carlos III) ;
Rodríguez, Isabel (Instituto de Salud Carlos III) ;
Valdivielso, José M. (Instituto de Salud Carlos III) ;
Aladrén Regidor, Mª José (Hospital Comarcal Ernest Lluch) ;
Almirall Daly, Jaume (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Ponz, Esther (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Arteaga Coloma, Jesús (Complejo Hospitalario de Navarra) ;
Bajo Rubio, Mª Auxiliadora (Raquel Hospital la Paz) ;
Díaz, Raquel (Raquel Hospital la Paz) ;
Belart Rodríguez, Montserrat (Sistemes Renals) ;
Gascón, Antonio (Hospital Obispo Polanco) ;
Bover, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Bronsoms Artero, Josep (Clínica Girona) ;
Cabezuelo Romero, Juan B. (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ;
Muray Cases, Salomé (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ;
Calviño Varela, Jesús (Hospital Universitario Lucus Augusti (Lugo)) ;
Caro Acevedo, Pilar (Clínica Ruber) ;
Carreras Bassa, Jordi (Diaverum Baix Llobregat) ;
Cases Amenós, Aleix (Hospital Clínic i Provincial de Barcelona) ;
Massó Jiménez, Elisabet (Hospital Clínic i Provincial de Barcelona) ;
Moreno López, Rosario (Hospital de la Defensa) ;
Cigarrán Guldris, Secundino (Hospital da Costa) ;
López Prieto, Saray (Hospital da Costa) ;
Comas Mongay, Lourdes (Hospital General de Vic) ;
Comerma, Isabel (Hospital General de Manresa) ;
Compte Jové, MªTeresa (Hospital de la Santa Creu de Jesús) ;
Cuberes Izquierdo, Marta (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ;
De Álvaro, Fernando (Hospital Universitario Infanta Sofía (San Sebastián de los Reyes)) ;
Hevia Ojanguren, Covadonga (Hospital Universitario Infanta Sofía (San Sebastián de los Reyes)) ;
De Arriba De La Fuente, Gabriel (Hospital Universitario de Guadalajara) ;
Del Pino Y Pino, Mª Dolores (Complejo Hospitalario Torrecardenas de Almeria) ;
Diaz-Tejeiro Izquierdo, Rafael (Francisco Hospital Virgen de la Salud) ;
Hormigos, Ahijado (Francisco Hospital Virgen de la Salud) ;
Dotori, Marta (USP Marbella) ;
Duarte, Verónica (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
Estupiñan Torres, Sara (Hospital Universitario de Canarias (La Laguna)) ;
Fernández Reyes, MªJosé (Hospital de Segovia) ;
Fernández Rodríguez, Mª Loreto (Hospital Príncipe de Asturias) ;
Fernández, Guilermina (Clínica Santa Isabel) ;
Galán Serrano, Antonio (Hospital General Universitari de València) ;
García Cantón, Cesar (Hospital Universitario Insular de Gran Canaria) ;
García Herrera, Antonio L. (Hospital Universitario Puerto Real (Cadis)) ;
García Mena, Mercedes (Hospital San Juan de Dios) ;
Gil Sacaluga, Luis (Hospital Virgen Del Rocío) ;
Aguilar, Maria (Hospital Virgen Del Rocío) ;
Górriz, José Luis (Hospital Universitari Doctor Peset (València)) ;
Huarte Loza, Emma (Hospital San Pedro de Alcántara) ;
Lerma, José Luis (Hospital Universitario de Salamanca) ;
Liebana Cañada, Antonio (Hospital de Jaén) ;
Marín Álvarez, Jesús Pedro. (Hospital San Pedro de Alcántara) ;
Martín Alemany, Nadia (Hospital Universitari de Girona Doctor Josep Trueta) ;
Martín García, Jesús (Hospital Nuestra Señora de Sonsoles (Àvila)) ;
Martínez Castelao, Alberto (Hospital Universitari de Bellvitge) ;
Martínez Villaescusa, María (Complejo Hospitalario Universitario de Albacete) ;
Martínez, Isabel (Hospital Galdakao) ;
Moina Eguren, Iñigo (Hospital Basurto) ;
Moreno Los Huertos, Silvia (Hospital Santa Bárbara) ;
Mouzo Mirco, Ricardo (Hospital El Bierzo Ponferrada) ;
Munar Vila, Antonia (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Muñoz Díaz, Ana Beatriz (Hospital Vithas Nisa Virgen Del Consuelo) ;
Navarro González, Juan F. (Hospital Universitario Nuestra Señora de Candelaria (Santa Cruz de Tenerife)) ;
Nieto, Javier (Hospital General Universitario de Ciudad Real) ;
Carreño, Agustín (Hospital General Universitario de Ciudad Real) ;
Novoa Fernández, Enrique (Complexo Hospitalario de Ourense) ;
Ortiz, Alberto (Fundacion Jimenez Diaz) ;
Fernandez, Beatriz (Fundacion Jimenez Diaz) ;
Paraíso, Vicente (Hospital Universitario del Henares (Madrid)) ;
Pérez Fontán, Miguel (Complejo Hospitalario Universitario de A Coruña) ;
Peris Domingo, Ana (Hospital Francesc de Borja) ;
Piñera Haces, Celestino (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Prados Garrido, Mª Dolores (Hospital Universitario San Cecilio (Granada)) ;
Prieto Velasco, Mario (Hospital Universitario de León) ;
Puig Marí, Carmina (Hospital D'Igualada) ;
Rivera Gorrín, Maite (Hospital Universitario Ramón y Cajal (Madrid)) ;
Rubio, Esther (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Ruiz, Pilar (Hospital de Sant Joan Despí Moisès Broggi) ;
Salgueira Lazo, Mercedes (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ;
Martínez Puerto, Ana Isabel (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ;
Sánchez Tomero, José Antonio (Hospital Universitario de la Princesa (Madrid)) ;
Sánchez, José Emilio (Hospital Universitario Central de Asturias) ;
Sans Lorman, Ramon (Hospital de Figueres) ;
Saracho, Ramon (Hospital de Santiago) ;
Sarrias, Maria (Hospital Universitari Vall d'Hebron) ;
Seron, Daniel (Hospital Universitari Vall d'Hebron) ;
Soler, María José (Hospital del Mar (Barcelona, Catalunya)) ;
Barrios, Clara (Hospital del Mar (Barcelona, Catalunya)) ;
Sousa, Fernando (Hospital Rio Carrión) ;
Toran, Daniel (Hospital General de Jerez) ;
Tornero Molina, Fernando (Hospital Universitario Del Sureste) ;
Usón Carrasco, José Javier (Hospital Virgen de La Luz (Cuenca)) ;
Valera Cortes, Iidefonso (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Vilaprinyo del Perugia, Mª Merce (Institut Catala d'Urologia i Nefrologia) ;
Virto Ruiz, Rafael C. (Hospital San Jorge) ;
Carratalá, Vicente Pallarés (Clinica MEDEFIS) ;
Altozano, Carlos Santos (CS Azuqueca de Henares) ;
Ródenas, Miguel Artigao (CS Zona III) ;
Gil, Inés Gil (Área Básica Sanitaria de Arán) ;
Gil, Francisco Adan (CS Alfaro) ;
Criado, Emilio García (Centro de Salud Del Carpio) ;
Belinchón, Rafael Durá (CS Godella) ;
Ma Fernández Toro, Jose (CS Zona Centro) ;
Antonio Divisón Garrote, Juan (Consultorio de Fuentealbilla) ;
Universitat Autònoma de Barcelona
Chronic kidney disease (CKD) is a major risk factor for end-stage renal disease, cardiovascular disease and premature death. Despite classical clinical risk factors for CKD and some genetic risk factors have been identified, the residual risk observed in prediction models is still high. [...]
2019 - 10.3389/fgene.2019.00118
Frontiers in genetics, Vol. 10 Núm. FEB (2019) , p. 118
|
|
|
3.
|
|
10 p, 396.0 KB |
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events : The ODYSSEY OUTCOMES Trial
/
Szarek, Michael (State University of New York) ;
White, Harvey D. (University of Auckland and Green Lane Cardiovascular Services Auckland City Hospital) ;
Schwartz, Gregory G. (Division of Cardiology. University of Colorado School of Medicine) ;
Alings, Marco (Amphia Ziekenhuis Molengracht) ;
Bhatt, Deepak L (Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School) ;
Bittner, Vera A. (University of Alabama at Birmingham) ;
Chiang, Chern-En (Taipei Veterans General Hospital and National Yang-Ming University) ;
Diaz, Rafael (Instituto Cardiovascular de Rosario) ;
Edelberg, Jay M. (Sanofi) ;
Goodman, Shaun G. (University of Toronto) ;
Hanotin, Corinne (Sanofi) ;
Harrington, R.A. (Stanford University) ;
Jukema, J.Wouter (Leiden University Medical Center) ;
Kimura, Takeshi (Kyoto University Graduate School of Medicine) ;
Kiss, Robert Gabor (Magyar Honvédség Egészségügyi Központ) ;
Lecorps, Guillaume (Sanofi) ;
Mahaffey, Kenneth W. (Stanford University) ;
Moryusef, Angèle (Sanofi) ;
Pordy, Robert (Regeneron Pharmaceuticals Inc.) ;
Roe, Matthew T. (Duke University Medical Center) ;
Tricoci, Pierluigi (Duke University Medical Center) ;
Xavier, Denis (St. John's Medical College and Research Institute) ;
Zeiher, Andreas Michael (Goethe University) ;
Steg, Ph Gabriel (Royal Brompton Hospital (Londres)) ;
Cequier Fillat, Angel R. (Hospital Universitari de Bellvitge) ;
Garcia-Dorado, David (Hospital Universitari Vall d'Hebron) ;
Matas Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ;
Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ;
Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Coca Payeras, Antonio (Hospital Clínic i Provincial de Barcelona) ;
Universitat Autònoma de Barcelona
The ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab) trial compared alirocumab with placebo, added to high-intensity or maximum-tolerated statin treatment, after acute coronary syndrome (ACS) in 18,924 patients. [...]
2019 - 10.1016/j.jacc.2018.10.039
Journal of the American College of Cardiology, Vol. 73 Núm. 4 (may 2019) , p. 387-396
|
|
|
4.
|
|
10 p, 324.1 KB |
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome : ODYSSEY OUTCOMES Trial
/
Jukema, J.Wouter (Leiden University Medical Center) ;
Szarek, Michael (State University of New York) ;
Zijlstra, Laurien E. (Leiden University Medical Center) ;
de Silva, H.Asita (University of Kelaniya) ;
Bhatt, Deepak L (Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School) ;
Bittner, Vera A. (University of Alabama at Birmingham) ;
Diaz, Rafael (Cardiovascular Institute of Rosario) ;
Edelberg, Jay M. (Sanofi) ;
Goodman, Shaun G. (St. Michael's Hospital. University of Toronto) ;
Hanotin, Corinne (Sanofi) ;
Harrington, Robert A. (Stanford University) ;
Karpov, Yuri (Russian Cardiological Scientific-Productive Complex) ;
Moryusef, Angèle (Sanofi) ;
Pordy, Robert (Regeneron Pharmaceuticals. Inc.) ;
Prieto, Juan C. (University of Chile Clinical Hospital) ;
Roe, Matthew T. (Duke University School of Medicine) ;
White, Harvey D. (Green Lane Cardiovascular Services Auckland City Hospital) ;
Zeiher, Andreas Michael (Goethe University) ;
Schwartz, Gregory G. (University of Colorado School of Medicine) ;
Steg, P.Gabriel (Royal Brompton Hospital (Londres)) ;
Cequier, Ángel (Hospital Universitari de Bellvitge) ;
García-Dorado, David (Hospital Universitari Vall d'Hebron) ;
Mata Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ;
Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ;
Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Coca Payeras, Antonio (Hospital Clínic i Provincial de Barcelona) ;
Universitat Autònoma de Barcelona
Patients with acute coronary syndrome (ACS) and concomitant noncoronary atherosclerosis have a high risk of major adverse cardiovascular events (MACEs) and death. The impact of lipid lowering by proprotein convertase subtilisin-kexin type 9 inhibition in such patients is undetermined. [...]
2019 - 10.1016/j.jacc.2019.03.013
Journal of the American College of Cardiology, Vol. 74 Núm. 9 (march 2019) , p. 1167-1176
|
|
|
5.
|
|
12 p, 648.4 KB |
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
/
Bittner, Vera A. (University of Alabama at Birmingham) ;
Szarek, Michael (State University of New York) ;
Aylward, Philip (South Australian Health and Medical Research Institute) ;
Bhatt, Deepak L. (Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School) ;
Díaz, Rafaël J. (Instituto Cardiovascular de Rosario) ;
Edelberg, Jay M. (Sanofi) ;
Fras, Zlatko (Univerza V Ljubljani) ;
Goodman, Shaun G. (University of Toronto) ;
Halvorsen, Sigrun (University of Oslo) ;
Hanotin, Corinne (Sanofi) ;
Harrington, Robert A. (Stanford University) ;
Jukema, J. Wouter (Leiden University Medical Center) ;
Loizeau, Virginie (Sanofi) ;
Moriarty, Patrick Maurice (University of Kansas Medical Center) ;
Moryusef, Angèle (Sanofi) ;
Pordy, Robert (Regeneron Pharmaceuticals Inc.) ;
Roe, Matthew T. (Duke University School of Medicine) ;
Sinnaeve, Peter (University of Leuven) ;
Tsimikas, Sotirios (University of California San Diego) ;
Vogel, Robert A. (University of Colorado School of Medicine) ;
White, Harvey D. (Green Lane Cardiovascular Services Auckland City Hospital) ;
Zahger, Doron (Soroka University Medical Center) ;
Zeiher, Andreas Michael (Goethe University) ;
Steg, Philippe Gabriel (Royal Brompton Hospital (Londres)) ;
Schwartz, Gregory G. (University of Colorado School of Medicine) ;
Matas Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ;
Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Coca Payeras, Antonio (Hospital Clínic i Provincial de Barcelona) ;
Cequier, Ángel (Hospital Universitari de Bellvitge) ;
García-Dorado, David (Hospital Universitari Vall d'Hebron) ;
Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ;
Universitat Autònoma de Barcelona
Lipoprotein(a) concentration is associated with cardiovascular events. Alirocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, lowers lipoprotein(a) and low-density lipoprotein cholesterol (LDL-C). [...]
2020 - 10.1016/j.jacc.2019.10.057
Journal of the American College of Cardiology, Vol. 75 Núm. 2 (21 2020) , p. 133-144
|
|
|
6.
|
|
14 p, 1.7 MB |
The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia
/
López-Millán, Belén (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Costales, Paula (EntreChemSL) ;
Gutiérrez-Agüera, Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Díaz de la Guardia, Rafael (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Roca Ho, Heleia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Vinyoles, Meritxell (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Rubio Gayarre, Alba (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Safi, Rémi (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Castaño Cardoso, Julio (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Romecín, Paola Alejandra (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Ramírez Orellana, Manuel (Instituto de Investigación Hospital Universitario de la Princesa) ;
Anguita, Eduardo (Hospital Clínico San Carlos (Madrid)) ;
Jeremias, Irmela (Research Unit Apoptosis in Hematopoietic Stem Cells. Helmholtz Zentrum München) ;
Zamora, Lurdes (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Rodríguez-Manzaneque, Juan Carlos (GENYO. Centre for Genomics and Oncological Research. Pfizer. Universidad de Granada. Junta de Andalucía) ;
Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Morís, Francisco (EntreChemSL) ;
Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Patients with AML harboring a constitutively active internal tandem duplication mutation (ITD) in the FMS-like kinase tyrosine kinase (FLT3) receptor generally have a poor prognosis. [...]
2022 - 10.3390/cancers14061593
Cancers, Vol. 14 Núm. 6 (3-2 2022) , p. 1593
|
|
|
7.
|
|
9 p, 21.0 MB |
Robust in Vitro and in Vivo Immunosuppressive and Anti-inflammatory Properties of Inducible Caspase-9-mediated Apoptotic Mesenchymal Stromal/Stem Cell
/
Romecín, Paola Alejandra (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Vinyoles, Meritxell (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
López-Millán, Belén (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Díaz de la Guardia, Rafael (GENYO. Centro Pfizer-Universidad de Granada-Junta de Andalucia de Genomica e Investigacion Oncologica) ;
Atucha, Noemí M. (Universidad de Murcia) ;
Querol, Sergi (Banc de Sang i Teixits) ;
Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Benitez, Raquel (Instituto de Parasitología y Biomedicina "López-Neyra") ;
Gonzalez-Rey, Elena (Instituto de Parasitología y Biomedicina "López-Neyra") ;
Delgado, Mario (Instituto de Parasitología y Biomedicina "López-Neyra") ;
Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Mesenchymal stromal stem/cells (MSC) therapies are clinically used in a wide range of disorders based on their robust HLA-independent immunosuppressive and anti-inflammatory properties. However, the mechanisms underlying MSC therapeutic activity remain elusive as demonstrated by the unpredictable therapeutic efficacy of MSC infusions reported in multiple clinical trials. [...]
2022 - 10.1093/stcltm/szab007
Stem Cells Translational Medicine, Vol. 11 Núm. 1 (march 2022) , p. 88-96
|
|
|
8.
|
|
13 p, 2.6 MB |
Engraftment characterization of risk-stratified AML in NSGS mice
/
Díaz de la Guardia, Rafael (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Velasco-Hernández, Talia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Gutiérrez-Agüera, Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Roca Ho, Heleia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Molina, Oscar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Nombela-Arrieta, Cesar (Department of Medical Oncology and Hematology. University and University Hospital Zurich) ;
Bataller, Alex (Hospital Clínic i Provincial de Barcelona) ;
Fuster, José Luis (Instituto Murciano de Investigación Biosanitaria) ;
Anguita, Eduardo (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ;
Vives, Susana (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Zamora, Lurdes (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Nomdedeu, Josep (Institut d'Investigació Biomèdica Sant Pau) ;
Gomez Casares, Maria Teresa (Hospital Universitario de Gran Canaria Dr. Negrín) ;
Ramírez, Manuel (Instituto de Investigación Hospital Universitario de la Princesa) ;
Lapillonne, Hélène (Haematology Laboratory. AP-HP. Hôpital Armand Trousseau. Centre de Recherche Saint-Antoine CRSA. INSERM. Sorbonne Université) ;
Ramos-Mejia, Verónica (GENYO. Centre for Genomics and Oncological Research. Pfizer/Universidad de Granada/Junta de Andalucía) ;
Rodríguez-Manzaneque, Juan Carlos (GENYO. Centre for Genomics and Oncological Research. Pfizer/Universidad de Granada/Junta de Andalucía) ;
Bueno, Clara (Centro de Investigación Biomédica en Red de Cáncer) ;
Lopez-Millan, Belen (GENYO. Centre for Genomics and Oncological Research. Pfizer/Universidad de Granada/Junta de Andalucía) ;
Menéndez Bujan, Pablo (Institució Catalana de Recerca i Estudis Avançats)
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Disease heterogeneity is well documented, and patient stratification determines treatment decisions. Patient-derived xenografts (PDXs) from risk-stratified AML are crucial for studying AML biology and testing novel therapeutics. [...]
2021 - 10.1182/bloodadvances.2020003958
Blood advances, Vol. 5 Núm. 23 (14 2021) , p. 4842-4854
|
|
|
9.
|
|
17 p, 2.1 MB |
Scanning the solutions for the sustainable supply of forest ecosystem services in Europe
/
Hernández-Morcillo, Mónica (Eberswalde University for Sustainable Development, Sustainable Forest Resource Economics) ;
Torralba, Mario (University of Göttingen. Department of Agricultural Economics and Rural Development) ;
Baiges, Teresa (Centre de Propietat Forestal) ;
Bernasconi, Andreas (Pan Bern AG) ;
Bottaro, Giorgia (University of Padova. Land Environment Agriculture and Forestry Department) ;
Brogaard, Sara (Lund University Centre for Sustainability Studies Lund University) ;
Bussola, Francesca (Forest Service of the Autonomous Province of Trento) ;
Díaz-Varela, Emilio Rafael (University of Santiago de Compostela) ;
Geneletti, Davide (University of Trento. Department of Civil, Environmental and Mechanical Engineering) ;
Grossmann, Carol M. (Forest Research Institute Baden-Wuerttemberg) ;
Kister, Jutta (University of Innsbruck. Department of Geography) ;
Klingler, Michael (University of Natural Resources and Life Sciences Vienna) ;
Loft, Lasse (Leibniz Centre for Agricultural Landscape Research) ;
Lovric, Marko (European Forest Institute Yliopistokatu) ;
Mann, Carsten (Eberswalde University for Sustainable Development) ;
Pipart, Nathalie (KU Leuven) ;
Roces-Díaz, José V. (Centre de Recerca Ecològica i d'Aplicacions Forestals) ;
Sorge, Stefan (Eberswalde University for Sustainable Development, Sustainable Forest Resource Economics) ;
Tiebel, Malin (University of Göttingen. Department of Agricultural Economics and Rural Development) ;
Tyrväinen, Liisa (Natural Resources Institute Finland) ;
Varela, Elsa (Centre de Ciència i Tecnologia Forestals de Catalunya) ;
Winkel, Georg (Forest and Wageningen University. Nature Conservation Policy Group) ;
Plieninger, Tobias (University of Göttingen. Department of Agricultural Economics and Rural Development)
Forests are key components of European multifunctional landscapes and supply numerous forest ecosystem services (FES) fundamental to human well-being. The sustainable provision of FES has the potential to provide responses to major societal challenges, such as climate change, biodiversity loss, or rural development. [...]
2022 - 10.1007/s11625-022-01111-4
Sustainability science, March 2022, p. 1-17
|
|
|
10.
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
